BACKGROUND/OBJECTIVES: Eucalyptus globulus is a medicinal plant extensively used by the Moroccan population for treating a range of illnesses, especially respiratory conditions. METHODS: This study aimed to assess the antioxidant and antibacterial properties of E. globulus essential oil and its individual fractions (F1, F2, and F3). Antioxidant activity was evaluated through iron-reducing power, 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), and 2,2-diphenyl-1-picrylhydrazyl (DPPH) assays. Antibacterial activity was tested using disk diffusion and dilution methods, supported by molecular docking studies. Furthermore, GC-MS analysis was conducted on the essential oil and its individual fractions. RESULTS: GC-MS analysis identified the major compounds in the essential oil and its fractions as eucalyptol (62.32-42.60%), globulol (5.9-26.24%), o-cymene (6.89-24.35%), cryptone (7.10-15.95%), terpinen-4-ol (2.43-15.24%), and α-pinene (2.46-7.89%). Fraction F3 displayed the highest antioxidant activity in DPPH (IC(50) = 3.329 ± 0.054 mg/mL) and ABTS assays (IC(50) = 3.721 ± 0.027 mg/mL), while fraction F2 was most effective in the FRAP assay (IC(50) = 1.054 ± 0.008 mg/mL). The essential oil and its fractions also showed antibacterial activity against Staphylococcus aureus, Staphylococcus epidermidis, Klebsiella pneumoniae, Enterobacter cloacae, Escherichia coli, and Acinetobacter baumannii. Molecular docking further corroborated these findings, supporting both antioxidant and antibacterial activities. CONCLUSIONS: The present findings demonstrate the antioxidant and antimicrobial properties of Eucalyptus globulus essential oil and its fractions, underscoring the need for further research to confirm their medicinal potential and explore pharmaceutical applications.
GC-MS Characterization and Bioactivity Study of Eucalyptus globulus Labill. (Myrtaceae) Essential Oils and Their Fractions: Antibacterial and Antioxidant Properties and Molecular Docking Modeling.
桉树(Eucalyptus globulus Labill.,桃金娘科)精油及其组分的GC-MS表征和生物活性研究:抗菌和抗氧化特性及分子对接模型。
阅读:12
作者:
| 期刊: | Pharmaceuticals | 影响因子: | 4.800 |
| 时间: | 2024 | 起止号: | 2024 Nov 19; 17(11):1552 |
| doi: | 10.3390/ph17111552 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
